Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model-Reference-Cited by-同舟云学术

Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model

Published:2013 Issue:6 Volume:5 Page:51
ISSN:1758-9193
Container-title:Alzheimer's Research & Therapy
language:en
Short-container-title:Alzheimers Res Ther

Author:

Meister Sabrina,Zlatev Iavor,Stab Julia,Docter Dominic,Baches Sandra,Stauber Roland H,Deutsch Mordechai,Schmidt Reinhold,Ropele Stefan,Windisch Manfred,Langer Klaus,Wagner Sylvia,von Briesen Hagen,Weggen Sascha,Pietrzik Claus U

Publisher

Springer Science and Business Media LLC

Subject

Cognitive Neuroscience,Clinical Neurology,Neurology

Reference37 articles.

1. Alzheimer's Disease

2. Alzheimer's disease: Aβ, tau and synaptic dysfunction

3. Cellular processing of β-amyloid precursor protein and the genesis of amyloid β-peptide

4. Water-soluble Aβ(N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains

5. Metalloprotease Meprin β Generates Nontoxic N-terminal Amyloid Precursor Protein Fragments in Vivo

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nose to brain delivery of flurbiprofen from a solid lipid nanoparticles-based thermosensitive in-situ gel.;Neuroscience Applied;2024

2. Transnasal-brain delivery of nanomedicines for neurodegenerative diseases;Frontiers in Drug Delivery;2023-08-11

3. Using Liposomal and Intranasal Drugs and Pioglitazone for the Treatment and Prevention of Alzheimer’s Disease (Review);Pharmaceutical Chemistry Journal;2023-04

4. Characterization of the Protein Corona of Three Chairside Hemoderivatives on Melt Electrowritten Polycaprolactone Scaffolds;International Journal of Molecular Sciences;2023-03-24

5. Nose-to-brain drug delivery for the treatment of Alzheimer’s disease: current advancements and challenges;Expert Opinion on Drug Delivery;2022-01-02